Director/PDMR Shareholding

Belluscura PLC

04 July 2024

 

4 July 2024

BELLUSCURA PLC

("Belluscura" or the "Company")

Director/PDMR Shareholding

Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that on 3 July 2024, David Poutney, Non-Executive Director of the Company, sold 4,350,000 ordinary shares of 1 penny each ("Ordinary Shares") held in his own name, and 3,800,000 Ordinary Shares were acquired by his self-invested pension plan ("SIPP") with the balance of 550,000 Ordinary Shares being acquired by his wife's, Vivienne Poutney and a person closely associated, SIPP.

Following this transfer, Mr Poutney, and his persons closely associated, remain interested in a total of 14,255,731 Ordinary Shares in the Company, representing 8.53 per cent. of the Company's issued Ordinary Share capital.

For further information please contact:

Belluscura plc	Tel: [phone]
Adam Reynolds, Chairman Robert Rauker, Chief Executive Officer
SPARK Advisory Partners Limited Nominated Adviser	Tel: [phone]
Neil Baldwin / Jade Bayat
Dowgate Capital Limited Broker	Tel: [phone]
Russell Cook / Nicholas Chambers
MHP Group Financial PR & Investor Relations	Tel: [phone] email: [e-mail]
Katie Hunt / Matthew Taylor

About Belluscura plc (https://belluscura.com/)

Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	David Poutney (PDMR)
2	Reason for notification
a)	Position / status	Non-Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer,  emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Belluscura plc
b)	LEI	213800BRJQZE56XBPW94
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.01 each in Belluscura plc ISIN: GB00BD3B8Z11
b)	Nature of the transaction	(i)            Sale of shares (ii)           Purchase of shares in SIPP
c)	Price(s) and volumes(s)	Price(s) Volumes(s) (i)            Sale: 16p (ii)           Purchase: 16p 4,350,000 3,800,000
d)	Aggregated information	n/a
e)	Date of the transaction	3 July 2024
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Vivienne Poutney
2	Reason for notification
a)	Position / status	Person closely associated of David Poutney
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer,  emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Belluscura plc
b)	LEI	213800BRJQZE56XBPW94
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.01 each in Belluscura plc ISIN: GB00BD3B8Z11
b)	Nature of the transaction	Purchase of shares in SIPP
c)	Price(s) and volumes(s)	Price(s) Volumes(s) 16p 550,000
d)	Aggregated information	n/a
e)	Date of the transaction	3 July 2024
f)	Place of the transaction	London Stock Exchange

 

END